Foster Dykema Cabot & Partners’s Idexx Laboratories IDXX Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$471K	Hold	895	–	–	0.03%	78
2026 Q1	$503K	Hold	895	–	–	0.03%	75
2025 Q4	$605K	Buy	895 +1	+0.1%	+$681	0.04%	71
2025 Q3	$571K	Hold	894	–	–	0.04%	81
2025 Q2	$479K	Hold	894	–	–	0.03%	83
2025 Q1	$375K	Buy	894 +10	+1%	+$4.34K	0.03%	83
2024 Q4	$365K	Buy	884 +809	+1,079%	+$355K	0.03%	93
2024 Q3	$37.9K	Buy	+75	New	+$36.4K	﹤0.01%	245

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Foster Dykema Cabot & Partners's IDXX Position: Q2 2026 in Review

Foster Dykema Cabot & Partners held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 895 shares worth $471K. The position accounts for 0.03% of the portfolio, ranked #78.

Foster Dykema Cabot & Partners first reported a position in IDXX in Q3 2024 and has held it in 8 quarters since. The position peaked at $605K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Foster Dykema Cabot & Partners held 895 shares of Idexx Laboratories worth $471K as of Q2 2026.
Foster Dykema Cabot & Partners left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.03% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #78 holding.
Foster Dykema Cabot & Partners first reported a position in Idexx Laboratories in Q3 2024 and has held it in 8 quarters since.
Foster Dykema Cabot & Partners's Idexx Laboratories position peaked at $605K in Q4 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.